Table 2 Galectin-3 is an independent factor for predicting the rapid progression of ACLF patients.

From: Plasma galectin-3 can be considered as a non-invasive marker to predict the prognosis of ACLF patients with new typing

 

Univariable

Multivariable

HR (95% CI)

P

HR (95% CI)

P

Gender

1.16 (0.27–4.99)

0.834

  

Age

1.01 (0.98–1.04)

0.601

  

ALT

0.99 (0.99-1.00)

0.183

  

AST

0.99 (0.99-1.00)

0.360

  

ALP

0.99 (0.99-1.00)

0.529

  

GGT

0.99 (0.99-1.00)

0.673

  

TBil

1.00 (1.00–1.00)

0.021

1.00 (0.99-1.00)

0.184

CHE

0.99 (0.99-1.00)

0.056

  

PTA

0.91 (0.87–0.95)

< 0.001

0.95 (0.87–1.04)

0.291

INR

2.58 (1.78–3.74)

< 0.001

1.87 (0.72–4.91)

0.201

Cr

1.00 (0.98–1.02)

0.912

  

Na+

0.91 (0.84–0.99)

0.033

  

WBC

1.09 (1.04–1.15)

0.001

  

N%

1.02 (0.99–1.06)

0.231

  

PLT

0.99 (0.98-1.00)

0.016

  

AFP

0.99 (0.99-1.00)

0.363

  

MELD

1.13 (1.06–1.22)

< 0.001

0.94 (0.85–1.05)

0.288

Galectin-3

1.07 (1.03–1.11)

< 0.001

1.05 (1.00-1.10)

0.037

Back to article page